Diagnostic Method for Detecting Muscle Growth Manipulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack a reliable and efficient way to detect artificially enhanced muscle growth in domestic animals, particularly in farm animals raised for meat production, which is essential for identifying breaches of regulatory standards and ensuring ethical meat sourcing.
Innovation Solution
A diagnostic method involving the quantification of anti-myostatin antibodies and additional myostatin pathway biomarkers in tissue or bodily fluid samples from domestic animals, compared to reference animals, to determine if muscle growth has been artificially manipulated, allowing for the identification of muscle growth manipulation regardless of the treatment history.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If myostatin pathway manipulation is used to enhance muscle growth in farm animals, then muscle mass increases faster, but detection of such manipulation becomes difficult
Solution Approach 1:
The patent implements a feedback mechanism by measuring anti-myostatin antibody levels in the animal's blood and comparing them to reference values. This feedback loop enables detection of manipulation by identifying abnormal antibody responses, thereby resolving the contradiction between enhanced muscle growth and detection difficulty.
Solution Approach 2:
The patent uses anti-myostatin antibodies as an intermediary marker to indirectly detect myostatin pathway manipulation. Instead of directly measuring myostatin activity, the method measures the immune system's response (antibody production) to manipulated myostatin, providing a reliable detection mechanism that doesn't interfere with the muscle growth enhancement process.
2Reliability
If comprehensive biomarker analysis is performed to improve detection accuracy, then manipulation detection reliability increases, but test complexity increases
Solution Approach 1:
The patent extracts and focuses on a specific, critical biomarker (anti-myostatin antibodies) from the complex myostatin pathway system. By isolating this single key indicator and comparing it to reference values, the method achieves reliable detection without requiring analysis of multiple biomarkers, thereby maintaining simplicity while ensuring accuracy.
3Reliability
If reference animal comparison is implemented to improve detection accuracy, then manipulation identification reliability increases, but measurement time increases
Solution Approach 1:
The patent applies preliminary action by establishing reference values from non-manipulated animals before conducting actual detection. These pre-established reference ranges enable rapid comparison and immediate identification of manipulated animals, eliminating the need for time-consuming real-time analysis and significantly reducing testing time while maintaining high accuracy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the reliable detection of muscle growth manipulation, even when the treatment history is unknown, by comparing antibody and biomarker levels, providing a means to distinguish between natural and artificially enhanced muscle growth, thus ensuring compliance with regulatory standards and consumer demands for ethically sourced meat.
Implementation Method 1
If myostatin is blocked from binding to its receptor by anti-myostatin antibodies, an increase in muscle growth is observed
Data Source
AI summary
The invention relates to a diagnostic method and kit for the detection of the manipulation of muscle growth in a domestic animal, wherein the amount of anti- myostatin antibodies and optionally additional myostatin pathway biomarkers in the domestic animal are quantified and compared to the amount of anti-myostatin antibodies and optionally additional myostatin pathway biomarkers present in at least one non-manipulated reference animal, wherein an increased amount of the anti- myostatin antibodies and optionally additional myostatin pathway biomarkers present in the sample relative to the non-manipulated reference animal is indicative for the manipulation of muscle growth in a domestic animal.